EBS (06/11/2020)
$99.00
SKU :
EBS__06_11_2020_
Please be aware that we may update information relating to this company/topic at any time, and updates will be available for purchase as a new report. If you are interested in obtaining access to all of our reports and all report updates, we also have a quarterly subscriptions available. Please contact for information about our subscription plans.
Emergent BioSolutions (EBS) is a global specialty life sciences company that develops and commercializes vaccines, drugs and devices that address biodefense threats. The Company is a preferred provider of biodefense products and services to the U.S. government under multi-year contracts. Its most valuable product, BioThrax is the only FDA-approved anthrax vaccine. The Company’s products are sold mainly in the U.S. as well as internationally.
